PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Benchmark for sequencing companies PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Types of sequencing technology platforms • Illumina synthesis • Ion semiconductor sequencing • Sequencing by ligation • Pyrosequencing • Single molecule, real-time (SMRT) sequencing PART 07: Reimbursement and coverage • Payer perspective: Validating next-generation sequencing • Coding • Challenge for payers in US • Next-generation tumor sequencing • Conclusion PART 08: Regulation of next-generation sequencing tests in US • Analytical performance of next-generation sequencing tests • Assessing clinical performance of next-generation sequencing tests PART 09: Market segmentation by product • Global DNA sequencing products market for reagents and consumables • Global DNA sequencing products market for equipment PART 10: Market segmentation by end-user PART 11: Geographical segmentation • DNA sequencing products market in Americas • DNA sequencing products market in EMEA • DNA sequencing products market in APAC PART 12: Market drivers • Understanding of human genomics • Development of rapid sequencing platforms • Decline in DNA sequencing costs • Incidence of chronic diseases PART 13: Impact of drivers PART 14: Market challenges • Limitations of DNA sequencing technology • Unfavorable reimbursement scenario • Limited skilled medical professionals PART 15: Impact of drivers and challenges PART 16: Market trends • Increase in partnerships and collaborations • Advances in personalized medicine • Focus on bioinformatics PART 17: Vendor landscape • Competitive scenario • Key news • Market share analysis 2015 • Illumina • Thermo Fisher Scientific • Roche Diagnostics • Pacific Biosciences • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Cost per genome 2001-2014 Exhibit 03: Cost per megabase of DNA sequence 2001-2014 Exhibit 04: Cost of next-generation sequencing platforms Exhibit 05: Global DNA sequencing products market 2015-2020 ($ billions) Exhibit 06: Five forces analysis Exhibit 07: Types of sequencing platforms Exhibit 08: Global DNA sequencing products market segmentation by product 2015 Exhibit 09: Global DNA sequencing products market for reagents and consumables 2015-2020 ($ billions) Exhibit 10: Global DNA sequencing products market for equipment 2015-2020 ($ billions) Exhibit 11: Global DNA sequencing products market segmentation by end-user 2015 Exhibit 12: Global DNA sequencing products market segmentation by geography 2015 Exhibit 13: Global DNA sequencing products market segmentation by geography 2020 Exhibit 14: Global DNA sequencing products market segmentation by geography 2015-2020 Exhibit 15: DNA sequencing products market in Americas 2015-2020 ($ billions) Exhibit 16: DNA sequencing products market in EMEA 2015-2020 ($ billions) Exhibit 17: DNA sequencing products market in APAC 2015-2020 ($ millions) Exhibit 18: Impact of drivers Exhibit 19: Impact of drivers and challenges Exhibit 20: Market share of vendors 2015 Exhibit 21: Illumina: Product portfolio Exhibit 22: Illumina: Key takeaways Exhibit 23: Thermo Fisher Scientific: Product portfolio Exhibit 24: Thermo Fisher Scientific: Key takeaways Exhibit 25: Roche Diagnostics: Product portfolio Exhibit 26: Roche Diagnostics: Key takeaways Exhibit 27: Pacific Biosciences: Key takeaways Exhibit 28: Other prominent vendors

Illumina, Thermo Fisher Scientific, Roche Diagnostics, Pacific Biosciences, AC-Gen Reading Life, Agilent Technologies, Beckman Coulter, Cofactor Genomics, DNA Link, Eurofins MWG Operon, Expression Analysis, GE HealthCare, Otogenetics, Oxford Nanopore.